BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 36937566)

  • 1. Luteolin: A promising natural agent in management of pain in chronic conditions.
    Ntalouka F; Tsirivakou A
    Front Pain Res (Lausanne); 2023; 4():1114428. PubMed ID: 36937566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From nature to therapy: Luteolin's potential as an immune system modulator in inflammatory disorders.
    Hussain MS; Gupta G; Goyal A; Thapa R; Almalki WH; Kazmi I; Alzarea SI; Fuloria S; Meenakshi DU; Jakhmola V; Pandey M; Singh SK; Dua K
    J Biochem Mol Toxicol; 2023 Nov; 37(11):e23482. PubMed ID: 37530602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of Luteolin in Neoplasms and Nonneoplastic Diseases.
    Rakoczy K; Kaczor J; Sołtyk A; Szymańska N; Stecko J; Sleziak J; Kulbacka J; Baczyńska D
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of luteolin and luteolin-morphine co-administration on acute and chronic pain and sciatic nerve ligated-induced neuropathy in mice.
    Hashemzaei M; Abdollahzadeh M; Iranshahi M; Golmakani E; Rezaee R; Tabrizian K
    J Complement Integr Med; 2017 Mar; 14(1):. PubMed ID: 28282295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luteolin as an anti-inflammatory and neuroprotective agent: A brief review.
    Nabavi SF; Braidy N; Gortzi O; Sobarzo-Sanchez E; Daglia M; Skalicka-Woźniak K; Nabavi SM
    Brain Res Bull; 2015 Oct; 119(Pt A):1-11. PubMed ID: 26361743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis-based medicines for chronic neuropathic pain in adults.
    Mücke M; Phillips T; Radbruch L; Petzke F; Häuser W
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012182. PubMed ID: 29513392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luteolin, a flavonoid with potential for cancer prevention and therapy.
    Lin Y; Shi R; Wang X; Shen HM
    Curr Cancer Drug Targets; 2008 Nov; 8(7):634-46. PubMed ID: 18991571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution and biological activities of the flavonoid luteolin.
    López-Lázaro M
    Mini Rev Med Chem; 2009 Jan; 9(1):31-59. PubMed ID: 19149659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luteolin binds Src, promotes STAT3 protein ubiquitination and exerts anti-melanoma effects in cell and mouse models.
    Li T; Fu X; Liu B; Wang X; Li J; Zhu P; Niu X; Bai J; Liu Y; Lu X; Yu ZL
    Biochem Pharmacol; 2022 Jun; 200():115044. PubMed ID: 35460630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting cell signaling and apoptotic pathways by luteolin: cardioprotective role in rat cardiomyocytes following ischemia/reperfusion.
    Xu T; Li D; Jiang D
    Nutrients; 2012 Dec; 4(12):2008-19. PubMed ID: 23235403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luteolin, inflammation and cancer: Special emphasis on gut microbiota.
    Franza L; Carusi V; Nucera E; Pandolfi F
    Biofactors; 2021 Mar; 47(2):181-189. PubMed ID: 33507594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of Luteolin in the Greek Flora, Isolation of Luteolin and Its Action for the Treatment of Periodontal Diseases.
    Arampatzis AS; Pampori A; Droutsa E; Laskari M; Karakostas P; Tsalikis L; Barmpalexis P; Dordas C; Assimopoulou AN
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes and its Complications: Role of Luteolin, A Wonder Chemical from the Natural Source.
    Pradhan G; Kulkarni YA
    Curr Diabetes Rev; 2024 Feb; ():. PubMed ID: 38425118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Expedition of Luteolin against Brain-related Disorders: An Updated Review.
    Singh NK; Bhushan B; Singh P; Sahu KK
    Comb Chem High Throughput Screen; 2024 Apr; ():. PubMed ID: 38659259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and neuroprotective phenotype.
    Dirscherl K; Karlstetter M; Ebert S; Kraus D; Hlawatsch J; Walczak Y; Moehle C; Fuchshofer R; Langmann T
    J Neuroinflammation; 2010 Jan; 7():3. PubMed ID: 20074346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory effects of luteolin: A review of in vitro, in vivo, and in silico studies.
    Aziz N; Kim MY; Cho JY
    J Ethnopharmacol; 2018 Oct; 225():342-358. PubMed ID: 29801717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gabapentin for chronic neuropathic pain and fibromyalgia in adults.
    Moore RA; Wiffen PJ; Derry S; Toelle T; Rice AS
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD007938. PubMed ID: 24771480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Anti-Nociceptive and Anti-Inflammatory Effect of Luteolin in Mice.
    Fan X; Du K; Li N; Zheng Z; Qin Y; Liu J; Sun R; Su Y
    J Environ Pathol Toxicol Oncol; 2018; 37(4):351-364. PubMed ID: 30806241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of luteolin in experimental ischemic stroke: upregulated SOD1, CAT, Bcl-2 and claudin-5, down-regulated MDA and Bax expression.
    Qiao H; Dong L; Zhang X; Zhu C; Zhang X; Wang L; Liu Z; Chen L; Xing Y; Wang C; Li Y
    Neurochem Res; 2012 Sep; 37(9):2014-24. PubMed ID: 22696246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PPARγ-dependent effect of flavonoid luteolin against damage induced by the chemotherapeutic irinotecan in human intestinal cells.
    Boeing T; Speca S; de Souza P; Mena AM; Bertin B; Desreumax P; Mota da Silva L; Faloni de Andrade S; Dubuqoy L
    Chem Biol Interact; 2022 Jan; 351():109712. PubMed ID: 34699766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.